GGrantIndex
← Leaderboards

Jose Alberola-Ila

Oklahoma Medical Research Foundation

$8,146,944
Attributed
$8,954,077
Total exposure
8
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $655.9K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,954,077 · 8

By mechanism

R01$7,350,944 · 4
R21$917,838 · 2
P20$685,295 · 2

Top collaborators

Most similar at Oklahoma Medical Research Foundation

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsProgramsBaseInfectionTranscription FactorPlayPathogenProductionMolecularT-LymphocyteResponseExperimental StudyHelper-Inducer T-LymphocyteImmune SystemCd8-Positive T-LymphocytesCytokineAntigensImmune ResponseGenerationsFamilyResearch StudyFlow CytometryGene ExpressionPhysiological

Grant awards (28)

Flow Cytometry Core$168,202
P20 · FY2025 · GM · contact PI
Flow Cytometry Core$154,294
P20 · FY2024 · GM · contact PI
Flow Cytometry Core$126,818
P20 · FY2023 · GM · contact PI
Characterization of a distinct NKT subset and its role in influenza responses$537,917
R01 · FY2022 · AI · contact PI
Flow Cytometry Core$117,991
P20 · FY2022 · GM · contact PI
Characterization of a distinct NKT subset and its role in influenza responses$537,917
R01 · FY2021 · AI · contact PI
Flow Cytometry Core$117,990
P20 · FY2021 · GM · contact PI
Characterization of a distinct NKT subset and its role in influenza responses$537,917
R01 · FY2020 · AI · contact PI
Characterization of a distinct NKT subset and its role in influenza responses$537,917
R01 · FY2019 · AI · contact PI
Characterization of a distinct NKT subset and its role in influenza responses$537,763
R01 · FY2018 · AI · contact PI
E protein activity regulates effector lineage differentiation of NKT and ILCs$257,250
R21 · FY2017 · AI · contact PI
E protein activity regulates effector lineage differentiation of NKT and ILCs$214,375
R21 · FY2016 · AI · contact PI
Hematopoietic Stem Cell Senescence$395,842
R01 · FY2013 · HL
Hematopoietic Stem Cell Senescence$403,425
R01 · FY2012 · HL
Hematopoietic Stem Cell Senescence$407,500
R01 · FY2011 · HL
Regulation of NKT cell development and function by c-Myb$201,713
R21 · FY2011 · AI · contact PI
Hematopoietic Stem Cell Senescence$407,500
R01 · FY2010 · HL
Regulation of NKT cell development and function by c-Myb$244,500
R21 · FY2010 · AI · contact PI
Role of GATA-3 During CD4/CD8 Lineage Commitment$318,327
R01 · FY2009 · AI · contact PI
Role of GATA-3 During CD4/CD8 Lineage Commitment$318,327
R01 · FY2008 · AI · contact PI
Role of GATA-3 During CD4/CD8 Lineage Commitment$324,492
R01 · FY2007 · AI · contact PI
Role of GATA-3 During CD4/CD8 Lineage Commitment$334,183
R01 · FY2006 · AI · contact PI
Role of GATA-3 During CD4/CD8 Lineage Commitment$358,425
R01 · FY2005 · AI
ROLE OF RAS IN T-CELL FATE DETERMINATION$295,411
R01 · FY2004 · AI
ROLE OF RAS IN T-CELL FATE DETERMINATION$286,809
R01 · FY2003 · AI
ROLE OF RAS IN T-CELL FATE DETERMINATION$278,455
R01 · FY2002 · AI
ROLE OF RAS IN T-CELL FATE DETERMINATION$270,345
R01 · FY2001 · AI
ROLE OF RAS IN T-CELL FATE DETERMINATION$262,472
R01 · FY2000 · AI